Fundraising Fox
/Companies
Sign in

Neuraura

Calgary, CA · Founded 2017 · 11 employees on LinkedIn · 3 known investors

Find your way into Neuraura

Sign up to see every warm intro you have to Neuraura

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Neuraura team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Neuraura Biotech develops proprietary 3D micro-electrode and microsensor technology for high-fidelity neural recording and percutaneous stimulation, used to improve diagnostic and therapeutic solutions for neurological, psychiatric and sensory conditions. The company commercializes technology transferred from the University of Calgary, with a stated focus on chronic, underserved health conditions including women's health.

BiotechFemTechHealthtechMedical Devices

Founders & leadership

Neuraura was founded in 2017 by Claire Dixon and Pierre Wijdenes.

CDClaire Dixon
Claire DixonCEO and Co-FounderCEO and co-founder of Neuraura Biotech, which develops micro-electrode and microsensor technology for neural recording and stimulation to address neurological and psychiatric conditions. Dixon brings over 25 years of leadership and operational experience in technology-intensive industries.
PWPierre Wijdenes
Pierre WijdenesCPO and Co-FounderPierre Wijdenes is Chief Product Officer and co-founder of Neuraura Biotech, which develops micro-electrode and microsensor technology for neural recording and stimulation. He has worked as an entrepreneur and strategy consultant in healthcare.

Investors · 3

Startup TNTlisted by Startup TNTEdmonton · $5K – $100K
BoxOne VenturesreportedMontréal · $500K

How we know: the VCSheet dataset · Not right? Tell us

Related companies · 3

Nura BioNura Bio develops neuroprotective medicines targeting neurological diseases by translating scientific advances in axonal degeneration and neuroimmune regulation into novel therapeutics.
NeurasignalNeuraSignal develops FDA-cleared robotic transcranial Doppler (TCD) ultrasound technology that uses robotics and machine learning to provide real-time, noninvasive monitoring of cerebral blood flow. Its system supports stroke care workflows in hospitals and neurology clinics, including PFO detection and monitoring for shunts, vasospasm, and emboli.
Neuraptive TherapeuticsNeuraptive is a biotechnology company staffed by professionals with expertise in research and development, manufacturing, and commercialization in the pharmaceutical industry.

Companies working in the same space as Neuraura.

Frequently asked questions

What does Neuraura do?
Neuraura Biotech develops proprietary 3D micro-electrode and microsensor technology for high-fidelity neural recording and percutaneous stimulation, used to improve diagnostic and therapeutic solutions for neurological, psychiatric and sensory conditions. The company commercializes technology transferred from the University of Calgary, with a stated focus on chronic, underserved health conditions including women's health.
Who founded Neuraura?
Neuraura was founded by Claire Dixon, Pierre Wijdenes in 2017.
Who are Neuraura's investors?
Neuraura's investors include Iaso Ventures, Startup TNT, BoxOne Ventures.
Where is Neuraura headquartered?
Neuraura is headquartered in Calgary, CA.